Search for: "Teva Pharmaceuticals"
Results 261 - 280
of 1,430
Sort by Relevance
|
Sort by Date
18 Jun 2019, 8:59 pm
According to lawmakers, “Executives at Teva Pharmaceuticals allegedly orchestrated a sophisticated scheme to collude surreptitiously with competitors, artificially inflate the prices of over a hundred generic drugs, and destroy evidence of criminal conduct. [read post]
18 Jun 2019, 6:42 am
Over the last 14 years that I have published this blog, I have compiled an annual review with a list of key Delaware corporate and commercial decisions that have widespread utility to practitioners, especially those court decisions that are not widely covered by other legal publications or the mainstream press. [read post]
6 Jun 2019, 11:35 pm
Sara MoranThe Court of Appeal dismissed Synthon’s appeal against the Patent Court’s finding that the patent in suit did involve an inventive step over the prior art, and Teva’s appeal against the Court’s finding that certain claims of the patent were invalid for added matter. [read post]
6 Jun 2019, 6:49 am
Teva Pharmaceuticals USA, Inc. [read post]
5 Jun 2019, 2:37 pm
Teva Pharmaceuticals USA, Inc. [read post]
5 Jun 2019, 2:37 pm
Teva Pharmaceuticals USA, Inc. [read post]
30 May 2019, 6:02 am
Purdue Pharma and Teva, two of the nation’s largest supplier of opioids, have already reached multi-million dollar settlements with the state. [read post]
21 May 2019, 6:18 am
They can be “subsumed within an already tightly circumscribed legal analysis,” as the court recently explained in the patent-construction context in Teva Pharmaceuticals USA Inc. v. [read post]
16 May 2019, 9:30 am
Frost is a biotech billionaire who is CEO and chairman of Opko Health and former chairman of Teva Pharmaceutical Industries Ltd. [read post]
16 May 2019, 8:15 am
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
16 May 2019, 8:15 am
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
15 May 2019, 5:27 am
Kluwer Patent blogger44 U.S. states filed a lawsuit last Friday accusing Teva Pharmaceuticals USA of conspiring illegally with 19 other drug companies to inflate drug prices – sometimes by more than 1,000 percent – and stifle competition for generic drugs. [read post]
14 May 2019, 11:24 am
Teva Pharm. [read post]
14 May 2019, 7:50 am
The complaint was filed in the District Court for the District of Connecticut and names Teva Pharmaceuticals along with 19 other companies and 15 individuals who are senior executives at the heart of the scandal. [read post]
13 May 2019, 1:45 pm
Enlarge / A Teva facility in France. [read post]
13 May 2019, 8:48 am
Ltd. was supplying the active ingredient valsartan—a widely used treatment for high blood pressure that is taken alone, as well as sold in combination with other cardiovascular drugs—for major pharmaceutical companies such as Teva Pharmaceutical Industries Ltd., the largest generic drug maker in the world. [read post]
13 May 2019, 8:48 am
Ltd. was supplying the active ingredient valsartan—a widely used treatment for high blood pressure that is taken alone, as well as sold in combination with other cardiovascular drugs—for major pharmaceutical companies such as Teva Pharmaceutical Industries Ltd., the largest generic drug maker in the world. [read post]
10 May 2019, 11:15 am
This week in Other Barks & Bites, IPWatchdog's IP news roundup: the House of Representatives passes drug patent legislation, while antitrust legislation targeting patent-related activities is introduced into the Senate and the Trump administration mandates pricing information for pharmaceutical ads; the Patent Trial and Appeal Board (PTAB) issues a pair of precedential decisions on cases with multiple petitions; the USPTO issues marijuana-related trademark guidelines and a notice… [read post]
6 May 2019, 9:58 pm
Noonan -- Last Friday, the Federal Circuit affirmed a decision by the District Court that Defendants Actavis LLC and Teva Pharmaceuticals did not show by clear and convincing evidence that the claims asserted by Endo Pharmaceuticals Inc. and Mallinckrodt LLC were obvious, in Endo Pharmaceuticals Inc. v. [read post]
30 Apr 2019, 7:22 am
Prior to 2017, Canada had been the only G7 nation not to provide patent term extension for pharmaceutical products and was pressured into adopting this by the EU. [read post]
